# Rpk Pharmaceuticals Inc – FDA Inspection, Feb 28, 2019

Source: https://www.keypedia.com/records/fda_inspections/rpk-pharmaceuticals-inc/32fb44df-9b7a-445b-9b2e-fd6c48437eec
Source feed: FDA_Inspections

> FDA inspection 1081636 of Rpk Pharmaceuticals Inc, February 28, 2019. Classification: Voluntary Action Indicated (VAI). Form 483 issued. 4 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1081636
- Company Name: Rpk Pharmaceuticals Inc
- Inspection Date: 2019-02-28
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- [FDA Inspection 1155217 - 2021-10-14](https://www.keypedia.com/records/fda_inspections/rpk-pharmaceuticals-inc/29b04edb-3611-4cb7-836f-566da8a56f09)
- [FDA Inspection 771926 - 2012-03-08](https://www.keypedia.com/records/fda_inspections/rpk-pharmaceuticals-inc/e780fe8e-5ff4-4a18-91b8-4e47c32f5d1a)
- [FDA Inspection 660576 - 2010-04-09](https://www.keypedia.com/records/fda_inspections/rpk-pharmaceuticals-inc/e0cce943-b8eb-4be0-879e-6b807473056f)
- FDA Inspection 603965 - 2009-08-07

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/lucila-b-nwatu/3d1c9670-8206-425c-bddd-32e395293042)

Company: https://www.keypedia.com/companies/rpk-pharmaceuticals-inc/4fcc57aa-1dbd-44d8-859b-3754c50751af

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c